BIOCON:NSE
Biocon Ltd
348,50 INR
arrow_downward
-0,43%(-1,50) 1D
9. 10., 15:30:00 GMT+5:30 · INR
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro BIOCON…
Otevřít
349,55 INR
Max.
351,00 INR
Min.
343,95 INR
Trž. kap.
569,11 mld.
Prům. obj.
3,09 mil.
Objem
1,89 mil.
Dividenda
0,14 %
Čtvrtletní dividenda
0,12 INR
Datum ex dividenda
3. 7. 2026
Ukazatel P/E
103,17
52týd. max.
447,15 INR
52týd. min.
337,70 INR
EPS
3,38 INR
Akcie v oběhu
600,00 mil.
Počet zaměstnanců
16 tis.
Otevřít
349,55 INR
Max.
351,00 INR
Min.
343,95 INR
Trž. kap.
569,11 mld.
Prům. obj.
3,09 mil.
Objem
1,89 mil.
Dividenda
0,14 %
Čtvrtletní dividenda
0,12 INR
Datum ex dividenda
3. 7. 2026
Ukazatel P/E
103,17
52týd. max.
447,15 INR
52týd. min.
337,70 INR
EPS
3,38 INR
Akcie v oběhu
600,00 mil.
Počet zaměstnanců
16 tis.
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
Yahoo Finance
·
před 11 minutami
Gilead Has Outperformed the S&P 500. But is its Valuation Still Attractive?
The Motley Fool
·
před 7 minutami
Stock Market Pattern Echoes the Dot-Com Era and History Points to 1 Move Investors Should Make Now
MoneyWise.com
·
před 23 minutami
Warren Buffett's decades-old S&P 500 index fund advice is still paying dividends for investors
MarketWatch
·
před 1 dnem
S&P 500 at 10,000 or bust: New ETF offers investors all-or-nothing bet on the index
Profil
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Informace o Biocon Ltd
Generální ředitelShreehas P Tambe
Zaměstnanci16,4 tis.
Založeno29. 11. 1978
ÚstředíBengalúru, Karnátaka, Indie
Odvětví-
Webbiocon.com